Skip to main content
SEER logo

Seer, Inc. (SEER) Stock: Price, Forecast & Analyst Target

Seer, Inc. (SEER) — MoonshotScore 20/100 (Weak band), calculated Oct 4, 2026. Price $2.25 (+2.27%), as of the Oct 2, 2026 trading session; market cap $124M.

Educational signal · not a buy or sell recommendation · How to read this

$2.25 +$0.05 (+2.27%) Market Cap $124M

Seer, Inc. · SEER · NASDAQ

Seer, Inc. is a biotechnology company focused on developing innovative products for proteomic studies. The company aims to enhance research capabilities in therapeutic and diagnostic fields through its Proteograph Product Suite.

Price as of Oct 2, 2026

Key Statistics

20 of 100

MoonshotScore v2 · Seer (SEER)

Weak
Business Quality Thin (21)
Financial Safety Sound (75)
Valuation Full (53)
Growth Durability Flat (59)
Momentum Rising (78)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

A strong balance sheet, but bottom-tier quality; the market is already moving on it. Business Quality: Thin; Financial Safety: Sound; Valuation: Full; Growth Durability: Flat; Momentum: Rising.

  • quarterly revenue $3M (Q2 FY2026, quarter ended Jun 2026)
  • EPS beat 3 of 8
  • Altman Z -0.43 · Piotroski F 3

Holding back: weak fundamentals

Helping: balance-sheet strength, positive momentum

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for SEER (29 recorded, newest six shown)
RecordedScoreBand
19Weak
19Weak
20Weak
20Weak
20Weak
20Weak

The score was 20 in the stored Oct 3, 2026 snapshot and remains 20 in the current publication computed Oct 4, 2026 (0).

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · Educational signal · not a buy or sell recommendation · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$2.25
Change on the day+2.27%
52-week range$1.55 – $2.41
Market capitalisation$124M
Shares traded on the day200.5K

Price & events

Other perspectives

Council score for Seer (SEER): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

9-Factor Breakdown

Revenue Growth Neutral
Gross Margin Strong
Operating Leverage Neutral
Cash Runway Neutral
R&D Intensity Neutral
Insider Activity Moderate
Trading Liquidity Neutral
Price Momentum Negative
News Sentiment Neutral

Legends Council

4 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Griffin-style lens (simulated) Ken Griffin Favorable read
Englander-style lens (simulated) Izzy Englander Unfavorable read
Klarman-style lens (simulated) Seth Klarman Unfavorable read
Moon AI lens (model) Neutral read

Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Weak
Margin of Safety Undervalued
Profit Margin Weak
Revenue Growth Moderate
Debt/Equity Strong
ROE Negative
Gross Margin Moderate

Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Sep 10, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.

Readings on this page are from Oct 5, 2026, except a card that shows its own read date.

Watch the SEER film — every key number, told as a short cinematic story

~2 min · open the film

1 · What is it?

What is Seer (SEER), and what does it report?

Short answer · as of

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Seer, Inc. (SEER) is listed on NASDAQ. It employs 124 people and is led by Omid C. Farokhzad. In Q2 FY2026 it reported revenue of $3M and net income of -$17M. The market values it at $124M.

2 · Latest results

What do the latest results show for Seer (SEER)?

Short answer · as of

The most recent reported quarter, Q2 FY2026, carried revenue of $3M. Against analyst estimates the company has EPS beat 3 of 8 reports.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q2 FY2026$3M-$17M-$0.31 (diluted)
Q1 FY2026$3M-$17M-$0.30 (diluted)
Q4 FY2025$4M-$16M-$0.28 (diluted)
Q3 FY2025$4M-$18M-$0.32 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Seer (SEER)?

Short answer

The MoonshotScore pillars rate balance-sheet strength, positive momentum as strengths. What is holding it back is weak fundamentals. The distress and quality screens read Altman Z -0.43 · Piotroski F 3. Trailing ratios: ROE -26.6% · ROA -25.9% · current ratio 17.73 · earnings yield -78.2% · free-cash-flow yield -56.3%.

Data-derived red flags

  • Financial-distress signal — its Altman Z-Score of -0.43 sits in the distress zone (elevated bankruptcy risk).
  • Negative return on equity (-26.6%) — the business is not currently generating profit on shareholder capital.
  • Inconsistent delivery — missed Wall Street EPS estimates in 4 of the last 8 reported quarters.
4 · What to check next?

What should you watch next at Seer (SEER)?

Short answer · as of

Current published price targets run low $4.00 · high $4.00 · consensus $4.00 · median $4.00 against a quoted price of $2.25 (as of Oct 2, 2026).

What the records here don't tell us

  • No forward revenue or earnings estimate is on file.
  • The next earnings date is not yet scheduled in the calendar we read.

Checked against the records this page reads, on the dates shown above.

5 · Peer comparison

How does Seer compare with its peers?

Short answer

Seer's score ranks 4th of 4 in the bounded comparison shown, against 3 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Patterson-UTI Energy, Inc. (PTEN) Named competitor$11.21 Oct 2, 2026$4.26B34 5-pillar Oct 4, 2026
Prothena Corporation plc (PRTA) Named competitor$8.36 Oct 2, 2026$438M28 5-pillar Oct 4, 2026
AbCellera Biologics Inc. (ABCL) Named competitor$13.74 Oct 2, 2026$4.20B28 5-pillar Oct 4, 2026
Seer (SEER) — this page$2.25$124M20
Alopexx, Inc. (ALPX) Same industry, near in market value$9.96 Date unavailable$119M— Model unavailable
Rallybio Corporation (RLYB) Same industry, near in market value$17.08 Date unavailable$90.6M— Model unavailable
ImmuCell Corporation (ICCC) Same industry, near in market value$9.75 Date unavailable$88.2M— Model unavailable
Oramed Pharmaceuticals Inc. (ORMP) Same industry, near in market value$4.49 Date unavailable$184M— Model unavailable
AN2 Therapeutics, Inc. (ANTX) Same industry, near in market value$5.71 Date unavailable$206M— Model unavailable
Niagen Bioscience Inc (NAGE) Same industry, near in market value$2.79 Date unavailable$222M— Model unavailable
Q32 Bio Inc. (QTTB) Same industry, near in market value$8.23 Date unavailable$245M— Model unavailable
CorMedix Inc. (CRMD) Same industry, near in market value$7.19 Date unavailable$564M— Model unavailable
Zevra Therapeutics, Inc. (ZVRA) Same industry, near in market value$9.99 Date unavailable$591M— Model unavailable

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

The records behind this page

Analyst targets & estimates

What analysts have on file

Price target, low to high
$4.00 – $4.00
Consensus target
$4.00
Median target
$4.00

Consensus record · Captured .

Measured against a quoted price of $2.25 (as of Oct 2, 2026).

Insider activity

Form 4 records via FMP · Available records within the last 180 days, newest dated Aug 18, 2026 (coverage not recorded)

Transactions
17
Identified insiders
8
Purchases
0
Sales
3
Other transactions
14

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

What has been published about Seer (SEER)?

Read these with our analysis →

What Investors Ask About Seer (SEER)

These answers are editorial: 1 of these 9 answers is drawn from the SEER research dossier (written May 10, 2026 by gpt-4o-mini); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.

What does the MoonshotScore mean for SEER?

SEER carries the MoonshotScore stated above — the Weak band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers. Seer, Inc. is a biotechnology company focused on developing innovative products for proteomic studies.

Is SEER a good stock to buy?

Stock Expert AI does not rate SEER buy, sell or hold. Seer, Inc. carries a MoonshotScore, in the Weak band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the SEER stock price today?

The last price recorded on this page for Seer, Inc. (SEER) is $2.25, as of the Oct 2, 2026 trading session (source: Financial Modeling Prep (FMP) · quote). It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is the SEER price target?

The analyst consensus price target for Seer, Inc. (SEER) is $4.00 (range $4.00 to $4.00, median $4.00), per FMP data captured Oct 4, 2026. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.

What are the main risks for SEER?

Seer, Inc. faces several risks, including its significant negative profit margin, which raises concerns about financial sustainability. Additionally, the company operates in a highly competitive biotechnology landscape, where established players may threaten its market share.

What are the key factors to evaluate for SEER?

Seer, Inc. (SEER) holds a MoonshotScore in the low range. Analysts target $4.00 (+78%). Not financial advice.

How frequently does SEER data refresh on this page?

SEER's price is the last quote we recorded, from the Oct 2, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven SEER's recent stock price performance?

Seer, Inc. (SEER) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Innovative product offerings that address critical needs in proteomic research. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider SEER overvalued or undervalued right now?

Seer, Inc. (SEER) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Analysts target $4.00 (+78%) — upside seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Machine-generated analysis by Stock Expert AI — model gpt-4o-mini, generated May 10, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources — records for every figure on this page (21 figures)

The 21 rows below are exactly the facts the evidence-backed sections of this page printed — the 10-second verdict, the MoonshotScore, price and market value, the five questions with their receipts, and the records behind this page. Known dates and sources are recorded on their own rows; an em dash or UNRECORDED tier preserves a stored observation without inventing either. The quarterly income statement is provider-standardized (FMP) under one row, and scale definitions — a 0-100 rating, the band ladder, the Piotroski 0–9 range — are fixed rather than measured. No number in those sections was generated by a model. The register does not cover quoted third-party headlines, the dated council readings, or the Frequently Asked Questions; each of those says where it came from where it stands.

"As of" is the date the value is true for where the source carries one — a quarter end, a filing date, a price close, the day the score was computed. A cached observation with no source date remains undated; the page publication date is not used as a substitute.

FMP — 13 facts from Financial Modeling Prep endpoint families

FMP facts used on this page
Fact IDFactValue as shownAs ofTierSource
px.lastLatest provided price$2.25FMPFinancial Modeling Prep (FMP) · quote — Dated to the US trading session the price belongs to, derived from the quote record's timestamp (weekend and pre-open reads roll back to the previous weekday; exchange holidays are not modelled). The record does not establish an exchange execution time. Retrieved 2026-10-05T00:54:32.406Z.
px.changeChange on the day+2.27%FMPFinancial Modeling Prep (FMP) · quote
px.mcapMarket capitalisation$124MFMPFinancial Modeling Prep (FMP) · quote — Date unknown Market cap record date: 2026-10-02. FMP quote timestamp: 2026-10-02T20:00:00.000Z. Captured from FMP at 2026-10-05T00:54:31.422Z. No share-count basis is inferred; this page preserves the reported amount instead of recalculating it from shares.
px.change_absChange on the day, in dollars+$0.05FMPFinancial Modeling Prep (FMP) · quote
fin.q_revenueRevenue, Q2 FY2026$3MFMPFinancial Modeling Prep (FMP) · income statement (quarterly)
px.volumeShares traded on the day200.5KFMPFinancial Modeling Prep (FMP) · quote
fin.q_incomeNet income, Q2 FY2026-$17MFMPFinancial Modeling Prep (FMP) · income statement (quarterly)
fin.q_tableQuarterly income statement4 quarters through Q2 FY2026FMPFinancial Modeling Prep (FMP) · income statement (quarterly), as filed
earn.ptStored analyst price targetslow $4.00 · high $4.00 · consensus $4.00 · median $4.00FMPFinancial Modeling Prep (FMP) · price-target consensus — Captured Oct 4, 2026 · Coverage not supplied
earn.pt_rangeAnalyst price target, low to high$4.00 – $4.00FMPFinancial Modeling Prep (FMP) · price-target consensus — Captured Oct 4, 2026 · Coverage not supplied
earn.pt_consensusConsensus analyst price target$4.00FMPFinancial Modeling Prep (FMP) · price-target consensus — Captured Oct 4, 2026 · Coverage not supplied
earn.pt_medianMedian analyst price target$4.00FMPFinancial Modeling Prep (FMP) · price-target consensus — Captured Oct 4, 2026 · Coverage not supplied
own.insidersInsider transactions via FMP17 transactions · 0 purchases, 3 sales, 14 other transactions · 8 identified insiders · available records within the last 180 days, newest dated Aug 18, 2026 (coverage not recorded)FMPFinancial Modeling Prep (FMP), carrying Form 4 transaction records — Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

UNRECORDED — 6 facts from stored observations whose source was not recorded

UNRECORDED facts used on this page
Fact IDFactValue as shownAs ofTierSource
earn.historyReported versus estimated, recent quartersEPS beat 3 of 8UNRECORDEDStored earnings-history observation — Captured 2026-09-16 · Expired observation
fin.scoresDistress and quality screensAltman Z -0.43 · Piotroski F 3UNRECORDEDStored financial-scores observation — Captured 2026-10-03 · Expired observation
px.range5252-week range$1.55 – $2.41UNRECORDEDStored company-profile observation — Captured 2026-10-01
id.employeesEmployees124UNRECORDEDStored company-profile observation — Captured 2026-10-01
id.ceoChief executiveOmid C. FarokhzadUNRECORDEDStored company-profile observation — Captured 2026-10-01
fin.ratiosReturn and yield ratios (trailing twelve months)ROE -26.6% · ROA -25.9% · current ratio 17.73 · earnings yield -78.2% · free-cash-flow yield -56.3%—UNRECORDEDStored key metrics — Date unknown

OURS — 2 facts from Stock Expert AI's own score and rank

OURS facts used on this page
Fact IDFactValue as shownAs ofTierSource
ours.moonshotMoonshotScore v220 of 100 · Weak · pillars 21 / 75 / 53 / 59 / 78OURSStock Expert AI MoonshotScore v2 engine
ours.moonshot_changeMoonshotScore movement20 (stored snapshot Oct 3, 2026) → 20 (current publication computed Oct 4, 2026) (0)OURSStock Expert AI current score publication and immutable score snapshots
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.